Rhythm Pharmaceuticals, Inc. RYTM Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Rhythm Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s gross margin?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported gross margin of 89.4% in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s gross margin changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s gross margin decreased by 0.2% year-over-year, from 89.6% to 89.4%.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s gross margin?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s gross margin has grown at a 2.6% compound annual growth rate (CAGR), from 81% to 89.7%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.